Akt inhibition enhances the antitumor efficacy of immune checkpoint blockades and radiotherapy in a syngeneic breast cancer model. Park N, Jeon SH, Kim Y, Kim S, et al. Mol Ther Oncol 2025;33:201087.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park N, Jeon SH, Kim Y, Kim S, et al. Akt inhibition enhances the antitumor efficacy of immune checkpoint blockades and radiotherapy in a syngeneic breast cancer model. Mol Ther Oncol 2025;33:201087.
PMID: 41378083